Pulmonx Corporation (LUNG) Market Cap & Valuation Ratios
Pulmonx Corporation (LUNG) has a market cap of $78.6M and a price-to-sales ratio of 0.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LUNGPulmonx CorporationFollow LUNG — free
—
Price chart with a free account
- Market cap
- 78.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| LUNG | 0.1 | — | 0.7 | — | — | -3% | -53% | -179% |
| CLPT | 0.3 | — | 7.1 | — | -11.2% | +26% | -73% | -160% |
| TMCI | 0.3 | — | 1.4 | — | -9.0% | -4% | -26% | -42% |
| LAB | 0.2 | — | — | — | — | -5% | -113% | -36% |
| RXST | 0.2 | — | — | — | -13.0% | -4% | -36% | -23% |
| INGN | 0.2 | — | 0.2 | — | -5.1% | +3% | -9% | -34% |
| CATX | 0.2 | — | — | — | — | — | — | -49% |
| MXCT | 0.1 | — | 1.2 | — | — | -13% | -135% | -26% |
| QTRX | 0.1 | — | 0.3 | — | — | +22% | -100% | -87% |
| CVRX | 0.0 | — | 0.5 | — | — | +12% | -79% | -371% |
| NNOX | 0.0 | — | — | — | — | +35% | — | -269% |
| Median of these 10 | — | 0.9 | — | -10.1% | +3% | -76% | -45% |
; EV/Sales 0.7 vs. 0.9.
Growth vs. price
each dot a company · hover or tap for valuesPulmonx Corporation — questions
- What is Pulmonx Corporation's market cap?
- $78.6M.
- What is Pulmonx Corporation's price-to-sales ratio?
- 0.9.
Every figure on this page comes from Pulmonx Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.